AbbVie Inc.
0QCV.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$495.88B
Close$
$232.00
17.1% downside
Current Fair Value
17.1% downsideOvervalued by 17.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $495.88 Billion |
|---|---|
| Enterprise Value | $560.13 Billion |
| Dividend Yield | $6.83 (2.47%) |
| Earnings per Share | $2.36 |
| Beta | 0.47 |
| Outstanding Shares | 1,771,000,000 |
Return
| Return on Equity | -106.49% |
|---|---|
| Return on Assets | 4.68% |
| Return on Invested Capital | 17.29% |
Valuation & Multiples
| P/E Ratio | 77.89 |
|---|---|
| PEG | 27.25 |
| Price to Sales | 7.78 |
| Price to Book Ratio | -70.0 |
| Enterprise Value to Revenue | 8.7 |
| Enterprise Value to EBIT | 34.66 |
| Enterprise Value to Net Income | 88 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | -11.93 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$3.60
Average shareholder expectationRevenue Estimate
$16.78 B
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$17.32 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Abbvie Inc
57,000 employees
CEO: Richard Gonzalez AbbVie Inc. operates as a global pharmaceutical enterprise, concentrating on the discovery, development, production, and commercialization of medicinal products across the world. Its extensive product portfolio addresses various therapeu...